
News archive


Repros Receives Guidance From FDA For Upcoming Proellex Clinical Study
Repros Therapeutics Inc. announced that it has received guidance from the FDA for its clinical trial on Proellex, a drug candidate for the treatment of uterine fibroids. The agency recommended...